Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.58%, EPS grew 9.93%, free cash flow fell 45.0% and total debt rose 7.09%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
Follow EHC
Encompass Health Corporation (EHC) EV/Sales
As of 16 October 2026, Encompass Health Corporation (EHC) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 1.5× (March 2020) to 2.8× (January 2021); the current reading is higher than 91% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.2× | 1.89% |
| FY2024 | 2.2× | 11.57% |
| FY2023 | 1.9× | (2.29%) |
| FY2022 | 2.0× | (4.28%) |
| FY2021 | 2.1× | (22.21%) |
| FY2020 | 2.7× | 47.37% |
| FY2019 | 1.8× | 7.33% |
| FY2018 | 1.7× | 4.61% |
| FY2017 | 1.6× | (0.14%) |
| FY2016 | 1.6× | (9.46%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.0× | 1.67% |
| Mar 2026 | 2.0× | (10.02%) |
| Dec 2025 | 2.2× | (15.60%) |
| Sep 2025 | 2.6× | 0.79% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| THC Tenet Healthcare Corporation compare | 1.5× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| EHC Encompass Health Corporation | 2.4× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)